SE0402807D0 - Novel antimicrobial peptides - Google Patents

Novel antimicrobial peptides

Info

Publication number
SE0402807D0
SE0402807D0 SE0402807A SE0402807A SE0402807D0 SE 0402807 D0 SE0402807 D0 SE 0402807D0 SE 0402807 A SE0402807 A SE 0402807A SE 0402807 A SE0402807 A SE 0402807A SE 0402807 D0 SE0402807 D0 SE 0402807D0
Authority
SE
Sweden
Prior art keywords
antimicrobial peptides
novel antimicrobial
composition
peptides
antimicrobial
Prior art date
Application number
SE0402807A
Other languages
English (en)
Swedish (sv)
Inventor
Artur Schmidtchen
Martin Malmsten
Original Assignee
Dermagen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermagen Ab filed Critical Dermagen Ab
Priority to SE0402807A priority Critical patent/SE0402807D0/sv
Publication of SE0402807D0 publication Critical patent/SE0402807D0/sv
Priority to PCT/SE2005/001737 priority patent/WO2006054947A1/en
Priority to JP2007542974A priority patent/JP4898698B2/ja
Priority to CN2005800416016A priority patent/CN101068563B/zh
Priority to CA002588145A priority patent/CA2588145A1/en
Priority to US11/718,861 priority patent/US20080069849A1/en
Priority to HK08104872.7A priority patent/HK1114777B/xx
Priority to AU2005307160A priority patent/AU2005307160B2/en
Priority to KR1020077013664A priority patent/KR20070108142A/ko
Priority to EP05807139A priority patent/EP1817046A4/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1725—Complement proteins, e.g. anaphylatoxin, C3a or C5a
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicinal Preparation (AREA)
SE0402807A 2004-11-17 2004-11-17 Novel antimicrobial peptides SE0402807D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE0402807A SE0402807D0 (sv) 2004-11-17 2004-11-17 Novel antimicrobial peptides
PCT/SE2005/001737 WO2006054947A1 (en) 2004-11-17 2005-11-17 Novel antimicrobial peptides
JP2007542974A JP4898698B2 (ja) 2004-11-17 2005-11-17 新規抗菌性ペプチド
CN2005800416016A CN101068563B (zh) 2004-11-17 2005-11-17 新型抗微生物肽
CA002588145A CA2588145A1 (en) 2004-11-17 2005-11-17 Novel antimicrobial peptides
US11/718,861 US20080069849A1 (en) 2004-11-17 2005-11-17 Novel Antimicrobial Peptides
HK08104872.7A HK1114777B (en) 2004-11-17 2005-11-17 Novel antimicrobial peptides
AU2005307160A AU2005307160B2 (en) 2004-11-17 2005-11-17 Novel antimicrobial peptides
KR1020077013664A KR20070108142A (ko) 2004-11-17 2005-11-17 신규한 항미생물성 펩타이드
EP05807139A EP1817046A4 (en) 2004-11-17 2005-11-17 NEW ANTIMICROBIAL PEPTIDES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0402807A SE0402807D0 (sv) 2004-11-17 2004-11-17 Novel antimicrobial peptides

Publications (1)

Publication Number Publication Date
SE0402807D0 true SE0402807D0 (sv) 2004-11-17

Family

ID=33488268

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0402807A SE0402807D0 (sv) 2004-11-17 2004-11-17 Novel antimicrobial peptides

Country Status (9)

Country Link
US (1) US20080069849A1 (https=)
EP (1) EP1817046A4 (https=)
JP (1) JP4898698B2 (https=)
KR (1) KR20070108142A (https=)
CN (1) CN101068563B (https=)
AU (1) AU2005307160B2 (https=)
CA (1) CA2588145A1 (https=)
SE (1) SE0402807D0 (https=)
WO (1) WO2006054947A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090312265A1 (en) * 2006-02-10 2009-12-17 Dermagen Ab Novel antimicrobial peptides and use thereof
JP2009526046A (ja) * 2006-02-10 2009-07-16 デルマゲン アクティエボラーグ 新規分子
WO2007133153A1 (en) 2006-05-16 2007-11-22 Dermagen Ab Improved antimicrobial peptides
JP5384948B2 (ja) * 2007-02-09 2014-01-08 ジェノミディア株式会社 新規ポリペプチド及びそれを有効成分として含有する抗菌剤
EP2318584A1 (en) * 2008-08-13 2011-05-11 Dow Global Technologies LLC Process of fabricating peptide-coated fibers
WO2010019651A1 (en) * 2008-08-13 2010-02-18 Dow Global Technologies Inc. Peptide-coated fibers
US9376470B2 (en) 2008-11-28 2016-06-28 Funpep Inc. Polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes
US20110039763A1 (en) 2009-01-06 2011-02-17 C3 Jian, Inc. Targeted antimicrobial moieties
JP5750765B2 (ja) 2009-03-06 2015-07-22 株式会社ファンペップ ポリペプチド及びその抗菌または消毒用途
US8969311B2 (en) 2009-05-25 2015-03-03 Anges Mg, Inc. Polypeptide having antibacterial activity and angiogenesis-inducing activity and wound-healing drug containing said polypeptide
CN102596925A (zh) * 2009-06-08 2012-07-18 马萨诸塞州大学 抗微生物聚合物
EP3423477B1 (en) * 2015-06-30 2021-09-29 Chain Antimicrobials OY New antimicrobial peptides, their variants and uses
KR101855170B1 (ko) * 2015-11-18 2018-05-08 (주)노바셀테크놀로지 신규 항균 펩타이드 및 그의 용도
CN108324922A (zh) * 2018-04-16 2018-07-27 赵成群 一种预防和治疗妇科炎症的凝胶组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912230A (en) * 1991-11-01 1999-06-15 Periodontix, Inc. Anti-fungal and anti-bacterial histatin-based peptides
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
US5733872A (en) * 1993-03-12 1998-03-31 Xoma Corporation Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
AU1086595A (en) * 1993-11-08 1995-05-29 Demeter Biotechnologies, Ltd. Methylated lysine-rich lytic peptides and method of making same by reductive alkylation
JP3459314B2 (ja) * 1994-08-31 2003-10-20 社団法人農林水産技術情報協会 新規ペプチド、抗菌剤、新規ペプチド遺伝子、新規な組み換え体ｄｎａ及び新規ペプチドの製造法
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
IL121134A0 (en) * 1997-06-22 1997-11-20 Yeda Res & Dev Peptides and antiallergic compositions comprising them
SE0301431D0 (sv) * 2003-05-19 2003-05-19 Dermagen Novel antimicrobial peptides
US20060222653A1 (en) * 2004-11-12 2006-10-05 Xencor, Inc. Antibodies operably linked to selected chemoattractants

Also Published As

Publication number Publication date
HK1114777A1 (en) 2008-11-14
EP1817046A4 (en) 2011-12-28
CN101068563B (zh) 2011-12-07
EP1817046A1 (en) 2007-08-15
KR20070108142A (ko) 2007-11-08
CA2588145A1 (en) 2006-05-26
JP4898698B2 (ja) 2012-03-21
CN101068563A (zh) 2007-11-07
JP2008520660A (ja) 2008-06-19
AU2005307160A1 (en) 2006-05-26
AU2005307160B2 (en) 2011-06-16
WO2006054947A1 (en) 2006-05-26
US20080069849A1 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
SE0402807D0 (sv) Novel antimicrobial peptides
EP2194043A3 (en) Processes and intermediates
BRPI0807487A8 (pt) Uso de antagonistas de il-23 para o tratamento de infecção
WO2008115281A3 (en) Compounds for treating viral infections
CY1111212T1 (el) Θειικες ενωσεις ως αναστολεις της πρωτεασης σερινης ns3 του ιου της ηπατιτιδας γ
EA200701790A1 (ru) Твёрдый фармацевтический дозированный состав
DE602006020032D1 (de) Il-21-varianten
WO2007091958A8 (en) Novel antimicrobial peptides and use thereof
JO2515B1 (en) Gamma-Crystalline form of ivabradine hydrochloride,a process for its preparation and pharmaceutical composition containing it
EA201000329A1 (ru) Циклические депсипептиды
IL189452A0 (en) Therapy with cd4 binding peptides and radiation
EA201491511A1 (ru) Линейные пептидные антибиотики
CL2007000595A1 (es) Compuestos derivados de piperidina; composicion farmaceutica y uso para el tratamiento y/o profilaxis de enfermedades seleccionadas entre hipertension, insuficiencia cardiaca congestiva e insuficiencia renal entre otras.
DE602006018856D1 (de) Neue nutrazeutika-zusammensetzungen
DK1641820T3 (da) Fra RasGap afledt peptid til selektiv at dræbe kræftceller
UY30629A1 (es) Nuevo péptido de actinomadura namibiensis
WO2008070347A3 (en) Betulin-peptide conjugates
ITRM20040349A1 (it) Peptidi antibatterici e loro analoghi.
WO2006120563A3 (en) Antibacterial agents
EA200800698A1 (ru) Способ стабилизации фармацевтических форм для введения, включающих микроорганизмы
MX2010010876A (es) Piperidinas sustituidas como compuestos terapeuticos.
WO2006098621A3 (en) Cross-beta structure on microbial organisms
WO2014106798A3 (es) Péptidos antimicrobianos, composiciones que los comprende y usos
WO2007084488A3 (en) Adam10 and its uses related to infection
WO2010092014A3 (en) Pesticidal mixtures